Global Prescription Lens Market Size study, by Type (Single Vision, Bifocal, Trifocal, Progressive, Workspace Progressives, Others) by Application (Myopia, Hyperopia/Hypermetropia, Astigmatism, Presbyopia), by Coating (Anti-reflective, Scratch Resistant C

Global Prescription Lens Market Size study, by Type (Single Vision, Bifocal, Trifocal, Progressive, Workspace Progressives, Others) by Application (Myopia, Hyperopia/Hypermetropia, Astigmatism, Presbyopia), by Coating (Anti-reflective, Scratch Resistant Coating, Anti-fog Coating, Ultraviolet Treatment) and Regional Forecasts 2022-2028

Global Prescription Lens Market is valued approximately USD 45.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.30% over the forecast period 2022-2028. Cases of vision impairment caused by refractive errors are on the rise. The majority of these cases go unreported at first and contribute to the growing frequency of uncorrected refractive defects (URE). Patients with refractive problems are often ignorant of their condition and receive no therapy. As a result, several organizations specializing on the diagnosis and treatment of refractive errors are being formed in order to control the rise in URE. Sightsavers, a non-profit organization with operations in over 30 countries, focuses mostly on the African and Asian continents. To deliver sophisticated and inexpensive ophthalmic therapy, the organization creates an alliance with local, regional, national, and international partners and governments. To address the issue of URE, the group devised a refractive error method. In accordance with its dual-track methodology, the company provides refractive error services. Furthermore, the organization is extending its programme alliances and developing collaborations to improve URE services. The existence of such organizations, as well as increased awareness of refractive error therapy, are projected to boost the market. The rising prevalence of refractive defect cases, namely myopia and astigmatism, is predicted to fuel prescription lens demand. According to a WHO report, the global incidence of myopia was 33% in 2020 and is anticipated to rise to 52% by 2050. East Asia has the largest frequency of the illness, with China, the Republic of Korea, Japan, and Singapore accounting for over half of the regional share. Prescription lenses aid in the resolution of the eyes' failure to transfer light onto the retina for improved vision. These lenses come in a variety of forms and coatings and are favoured based on refractive order. Concave prescription lenses are used to treat myopia, whereas convex prescription lenses are used to correct hyperopia. Cylindrical prescription lenses are used to correct astigmatism. However, the high cost of Prescription Lens stifles market growth throughout the forecast period of 2022-2028.

The key regions considered for the Global Prescription Lens Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific accounted for the most revenue share and is predicted to increase at the quickest rate over the projection period. The region's growing frequency of refractive defects is increasing the number of patients and, as a result, the need for prescription lenses for their treatment. The rising prevalence of myopia and presbyopia in nations such as the United States and Canada leads to North America representing the second-largest revenue share. Furthermore, big market companies are operating in the region and are developing new prescription lenses.

Major market player included in this report are:
Essilor
ZEISS International
HOYA VISION CARE COMPANY
VISION EASE
SEIKO OPTICAL PRODUCTS CO., LTD.
PRIVÉ REVAUX
Vision Rx Lab
De Rigo Vision SpA
Fielmann
Lanvin
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Type:
Single Vision
Bifocal
Trifocal
Progressive
Workspace Progressives
Others

By Application:
Myopia
Hyperopia/Hypermetropia
Astigmatism
Presbyopia

By Coating:
Anti-reflective
Scratch Resistant Coating
Anti-fog Coating
Ultraviolet Treatment

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Prescription Lens Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Essilor
ZEISS International
HOYA VISION CARE COMPANY
VISION EASE
SEIKO OPTICAL PRODUCTS CO., LTD.
PRIVÉ REVAUX
Vision Rx Lab
De Rigo Vision SpA
Fielmann
Lanvin

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.